stage
tac
develop
valid
implement
site
laboratori
detail
figur
champ
tac
panel
design
cover
import
pathogen
newborn
infant
young
children
champ
site
base
upon
avail
inform
discuss
child
health
infecti
diseas
expert
overal
pathogen
target
design
modifi
exist
format
valid
use
tac
detect
bacteria
target
cover
genera
virus
target
cover
virus
parasit
target
target
per
organ
fungi
target
target
per
organ
tabl
need
assay
develop
differenti
speci
identifi
potenti
distinguish
clinic
meaning
featur
toxin
eg
pertussi
toxin
diphtheria
toxin
panel
initi
organ
separ
tac
configur
respiratori
enter
bloodcsf
tier
bloodcsf
tier
neonat
initi
period
test
approxim
year
reorgan
uniqu
configur
consolid
neonatalspecif
assay
bloodcsf
tier
tier
design
supplementari
figur
chang
simplifi
workflow
site
laboratori
perform
champ
tac
test
specimen
patient
test
set
tac
respiratori
enter
bloodcsf
tier
bloodcsf
tier
regardless
patient
age
card
configur
design
allow
test
specimen
along
neg
posit
control
run
ensur
data
qualiti
integr
sever
factor
consid
determin
configur
assay
within
card
design
empir
evalu
assay
perform
singleplex
multiplex
reaction
format
ensur
sensit
specif
neg
impact
multiplex
also
consid
optim
number
replic
brief
assay
spot
replic
respiratori
enter
configur
replic
case
blood
csf
configur
due
improv
sensit
higher
replic
test
whole
blood
specimen
observ
earlier
work
anoth
consider
organ
assay
blood
tier
tier
configur
ensur
assay
relat
multitarget
interpret
algorithm
includ
card
simplifi
data
manag
addit
target
previous
restrict
card
configur
acinetobact
baumannii
respiratori
enterococcu
faecali
enterococcu
faecium
enter
ad
bloodcsf
tac
configur
examin
impact
postmortem
dissemin
organ
respiratori
enter
tract
nich
realtim
pcr
assay
use
hydrolysi
probe
taqman
chemistri
design
microorgan
interest
tabl
subject
matter
expert
variou
divis
within
cdc
institut
consult
determin
best
genet
target
optim
sensit
specif
detect
desir
microorgan
oligonucleotid
design
use
primer
express
version
thermo
fisher
scientif
waltham
massachusett
primerquest
tool
integr
dna
technolog
idt
coralvil
iowa
wwwidtdnacomprimerquest
manual
via
sequenc
align
gene
target
region
use
clustal
omega
wwwebiacuktoolsmsaclustalo
case
whole
genom
multipl
sequenc
align
perform
use
progressivemauv
algorithm
confirm
presenc
target
region
target
organ
absenc
close
relat
speci
set
oligonucleotid
evalu
ensur
optim
melt
temperatur
thermocycl
condit
well
identifi
potenti
selfdimer
intermolecular
dimer
select
oligonucleotid
combin
oligonucleotid
assess
silico
basic
local
align
search
tool
analysi
genbank
nt
databas
wwwncbinlmnihgov
assess
specif
inclus
select
target
region
detect
appropri
group
organ
genu
speci
subtyp
etc
necessari
degener
base
includ
ensur
primerprob
bind
slightli
variabl
target
sequenc
region
probe
incorpor
minor
groov
binder
moieti
use
assay
increas
melt
temperatur
probe
short
stretch
nucleotid
identifi
suffici
sequenc
ident
across
variant
avail
within
public
databas
oligonucleotid
manufactur
idt
thermo
fisher
scientif
biotechnolog
core
facil
cdc
addit
silico
analys
assay
underw
empir
perform
evalu
includ
analyt
sensit
specif
inclus
specif
assess
extens
test
notempl
control
water
human
nucleic
acid
extens
list
microorgan
isol
bacteria
virus
protozoa
repres
genera
speci
previous
describ
test
perform
ensur
fals
amplif
due
oligomer
oligonucleotid
nonspecif
prime
event
lack
specif
target
sequenc
within
target
genu
speci
strain
type
analyt
sensit
determin
lower
limit
detect
independ
determin
assay
singleplex
applic
multiplex
format
test
least
replic
dilut
seri
specif
total
nucleic
acid
rang
inclus
assess
test
repres
isol
includ
variou
subspeci
serotyp
clonal
group
appropri
final
reaction
concentr
vari
nm
primer
nm
probe
individu
multiplex
realtim
pcr
reaction
assay
develop
valid
tac
product
qualiti
control
qc
perform
appli
biosystem
realtim
pcr
system
thermo
fisher
scientif
follow
cycl
condit
minut
minut
cycl
second
second
data
acquisit
occur
fam
vic
rox
andor
abi
channel
appropri
base
fluorophor
includ
multiplex
reaction
reaction
consist
qscript
xlt
reversetranscript
quantit
pcr
rtqpcr
toughmix
low
rox
quanta
bioscienc
gaithersburg
maryland
forward
revers
primer
hydrolysi
probe
fam
hex
vic
abi
correspond
quencher
molecul
total
nucleic
acid
templat
tac
run
assay
develop
valid
qc
conduct
cdc
specimen
test
site
laboratori
perform
previous
describ
use
either
appli
biosystem
quantstudio
flex
realtim
pcr
system
brief
mastermix
tac
consist
qscript
xlt
rtqpcr
toughmix
low
rox
nucleic
acid
templat
notempl
control
posit
control
consist
combin
rna
transcript
describ
includ
tac
multipl
realtim
pcr
assay
complex
togeth
duplex
triplex
reaction
use
differ
report
fluorophor
fam
vic
hex
abi
order
allow
detect
individu
target
singl
reaction
well
combin
assay
determin
base
silico
analysi
potenti
oligonucleotid
interact
empir
test
templat
assay
also
challeng
combin
high
low
templat
amount
ensur
equival
sensit
multiplex
reaction
situat
potenti
competit
compon
requir
amplif
polymeras
dntp
perform
characterist
select
duplex
triplex
reaction
confirm
use
small
batch
tac
manufactur
proofofconcept
test
multiplex
reaction
tac
particular
tac
use
assess
impact
reduc
reaction
volum
smaller
tac
compar
plate
format
use
assay
develop
lyophil
oligonucleotid
microfluid
array
perform
compat
differenti
label
oligonucleotid
probe
initi
triplex
reaction
evalu
probe
differenti
label
posit
fam
hex
modif
black
hole
quencher
bhq
fluoresc
quencher
molecul
despit
success
perform
plate
format
probe
perform
poorli
tac
case
assay
unabl
interpret
evalu
newer
report
dye
abi
thermo
fisher
scientif
replac
abylabel
probe
modifi
differ
quencher
molecul
qsi
exhibit
superior
perform
compar
tac
microfluid
card
format
howev
abylabel
probe
incompat
hexlabel
probe
multiplex
format
due
emiss
spectral
overlap
fluorophor
inadequ
quench
signal
use
bhq
compar
qsi
assay
perform
improv
replac
probe
version
elimin
spectral
crosstalk
multiplex
reaction
format
tac
also
evalu
probe
concentr
use
optim
probe
quencher
modif
includ
qsi
zen
doublequench
probe
idt
amplif
signal
substanti
improv
probe
compar
probe
intens
fam
fluoresc
approxim
higher
qsyquench
compar
bhqquench
probe
data
shown
use
quencher
allow
lower
final
concentr
probe
use
multiplex
reaction
use
save
cost
addit
evalu
plate
format
batch
tac
manufactur
vari
permut
probe
modif
report
quencher
reaction
concentr
compar
perform
singleplex
multiplex
reaction
format
tac
microfluid
system
assay
replac
unless
assay
requir
intern
quencher
case
use
overal
use
qsi
andor
zenibq
quencher
fam
vic
abi
report
dye
identifi
optim
combin
reducingremov
fluoresc
crosstalk
detect
channel
tac
qc
test
oligonucleotid
stock
reaction
mix
tac
product
individu
plasmid
contain
concaten
forward
primer
probe
revers
primer
revers
complement
sequenc
individu
target
within
multipl
clone
site
standard
clone
vector
plasmid
order
idt
thermo
fisher
scientif
stock
dilut
appropri
concentr
yield
posit
amplif
cross
threshold
ct
valu
ad
reaction
well
plate
format
load
portal
tac
control
assay
perform
tac
run
engin
combin
posit
control
expand
exist
pool
plasmid
contain
concaten
forward
primer
probe
revers
primer
revers
complement
sequenc
assay
includ
tac
configur
previous
describ
insert
spread
across
multipl
plasmid
due
limit
insert
size
transcript
length
vitro
transcript
perform
use
megascript
highyield
transcript
kit
appli
biosystem
previous
describ
transcript
pool
titrat
amplif
occur
ct
assay
singleus
aliquot
made
bulk
transcript
stock
divis
scientif
resourc
cdc
store
ship
site
laboratori
dri
ice
set
oligonucleotid
individu
assay
combin
final
reaction
concentr
assay
work
stock
combin
andor
dilut
appropri
gener
singleplex
duplex
triplex
assay
stock
final
concentr
assay
reaction
mix
qualiti
control
test
perform
test
multiplex
assay
mix
use
individu
plasmid
contain
concaten
forward
primer
probe
revers
primer
revers
complement
sequenc
assay
reaction
mix
templat
control
reaction
triplic
reaction
mix
ship
thermo
fisher
scientif
pleasanton
california
oligonucleotid
dilut
ship
milford
ohio
spot
onto
plastic
microfluid
array
tac
select
begin
middl
end
product
lot
qc
test
upon
receipt
lot
cdc
select
tac
use
confirm
spot
assay
design
reaction
well
use
plasmid
materi
preproduct
qc
templat
individu
lane
tac
store
ship
site
laboratori
insul
ship
box
cold
pack
product
lot
assign
uniqu
lot
number
tac
assign
uniqu
barcod
identif
number
consist
lot
number
follow
uniqu
identifi
develop
valid
specimen
process
nucleic
acid
extract
protocol
perform
pneumonia
respons
surveil
laboratori
cdc
use
mock
panel
clinic
specimen
spike
healthi
donor
blood
univers
transport
media
lung
tissu
stool
avail
archiv
clinic
specimen
use
magna
pure
compact
instrument
roch
diagnost
indianapoli
indiana
nucleic
acid
isol
kit
total
na
plasma
extern
lysi
protocol
platform
program
protocol
select
abil
accommod
larg
specimen
volum
input
offboard
lysi
procedur
ensur
inactiv
pathogen
microb
optim
releas
nucleic
acid
difficulttolys
microorgan
eg
gramposit
bacteria
fungi
parasit
specimen
type
requir
homogen
eg
lung
tissu
magna
pure
lc
total
nucleic
acid
isol
buffer
refil
magna
pure
bacteria
lysi
buffer
blb
roch
diagnost
select
specimen
inactiv
compat
roch
magna
pure
platform
abil
effect
lyse
eukaryot
prokaryot
cell
inactiv
nucleas
degrad
enzym
buffer
also
consid
test
necessari
modif
made
protocol
accommod
use
buffer
consist
avail
extract
platform
site
optim
mechan
disrupt
method
includ
test
bead
variou
materi
ceram
glass
stainless
steel
andor
size
perform
use
spike
whole
blood
frozen
lung
tissu
specimen
figur
final
protocol
specimen
process
nucleic
acid
extract
determin
select
combin
reagent
method
allow
detect
lowest
amount
difficulttolys
pathogen
organ
measur
realtim
pcr
supplementari
materi
final
laboratori
protocol
clinic
specimen
immedi
treat
blb
specimen
inactiv
undergo
addit
lysi
procedur
prior
extract
depend
specimen
type
figur
ensur
compar
perform
extract
platform
site
profici
test
panel
prepar
consist
univers
transport
media
whole
blood
stool
spike
quantifi
cultur
stock
specimen
extract
test
site
use
appropri
syndrom
tac
result
analyz
site
train
laboratori
staff
sent
pneumonia
respons
surveil
laboratori
cdc
evalu
result
use
inform
modif
extract
procedur
specif
extract
platform
instrument
instal
calibr
field
servic
technician
standard
dye
fam
vic
rox
custom
dye
abi
calibr
perform
instrument
routin
background
dye
calibr
perform
site
laboratori
staff
accord
manufactur
recommend
tac
run
initi
standard
run
templat
file
edt
appropri
card
configur
version
cycl
paramet
list
set
run
templat
ensur
consist
run
site
tac
test
minim
invas
tissu
sampl
mit
specimen
use
run
templat
also
ensur
assay
assign
proper
well
posit
report
dye
accur
result
run
templat
util
code
assay
consist
uniqu
letter
code
follow
version
number
indic
analyt
use
product
given
card
lot
uniqu
card
barcod
enter
scan
manual
entri
design
field
softwar
run
setup
ensur
proper
run
templat
use
specimen
type
standard
oper
procedur
tac
setup
also
specifi
standard
file
name
convent
compat
custom
databas
specifi
card
configur
site
date
run
oper
well
file
statu
unanalyz
analyz
site
review
cdc
onsit
laboratori
train
complet
site
respiratori
mening
pathogen
research
unit
soweto
south
africa
kenya
medic
research
institut
kisumu
kenya
manhica
health
research
centr
manhica
mozambiqu
site
haramaya
univers
harar
ethiopia
makeni
gener
hospit
makeni
sierra
leon
train
conduct
cdc
staff
site
icddr
b
dhaka
bangladesh
centr
vaccin
bamako
mali
handson
laboratori
train
includ
specimen
process
inactiv
beadbeat
etc
nucleic
acid
extract
use
sitespecif
platform
kit
tac
setup
perform
instrument
oper
tac
result
analysi
interpret
fundament
principl
multiplex
realtim
pcr
well
programspecif
procedur
emphas
train
session
technic
support
retrain
avail
need
train
also
provid
informat
staff
laboratori
andor
data
manag
staff
site
upload
data
champ
data
portal
ultim
object
champ
tac
data
manag
solut
gener
comprehens
report
tac
result
interpret
singl
champ
case
subject
within
packet
inform
compil
case
data
provid
case
packet
panel
expert
determin
caus
death
tac
report
must
distil
complex
instrument
output
format
easili
understood
user
varieti
healthrel
disciplin
thu
champ
tac
data
manag
solut
need
support
step
analysi
lifecycl
lead
final
report
analysi
process
use
instrument
softwar
creat
multipl
file
type
includ
analysi
run
file
ed
microsoft
excel
file
xlsx
contain
multipl
tab
data
run
ed
file
gener
real
time
amplif
process
proce
analyz
laboratori
staff
gener
posit
neg
indetermin
result
target
replic
intern
control
posit
control
notempl
control
card
assay
result
may
consid
indetermin
base
upon
perform
assay
specimen
control
reaction
qualiti
amplif
curv
assayspecif
limit
xlsx
file
export
file
contain
result
replic
associ
cycl
threshold
ct
valu
data
associ
run
champ
protocol
tac
analysi
specifi
analyst
retain
unanalyzed
file
analyzed
file
addit
xlsx
file
qc
reanalysi
requir
document
result
export
data
file
xlsx
contain
signific
amount
data
card
gener
row
result
depend
number
target
replic
target
associ
control
dataset
includ
either
replic
per
target
depend
card
type
must
interpret
arriv
singl
target
interpret
specimen
addit
pathogen
may
multipl
singl
target
interpret
must
interpret
group
gener
multitarget
result
typic
repres
subspeci
characterist
identifi
pathogen
level
supplementari
tabl
analysi
gener
final
result
xlsx
file
done
manual
process
tediou
potenti
error
prone
champ
program
project
analyz
thousand
tac
file
million
rowlevel
result
need
gener
data
manag
solut
would
provid
autom
interpret
storag
present
result
solut
new
subcompon
overal
champ
data
manag
web
portal
champ
site
upload
output
use
analysi
interpret
data
upon
upload
submit
file
valid
file
name
convent
structur
content
match
specimen
identifi
exist
champ
case
valid
error
result
reject
file
email
notif
sent
submitt
valid
error
card
pass
initi
valid
check
data
card
process
algorithm
gener
singletarget
replic
multitarget
interpret
store
replic
data
interpret
relat
databas
singletarget
replic
interpret
use
pattern
target
card
posit
replic
target
exist
interpret
posit
target
target
neg
result
replic
produc
neg
interpret
combin
neg
indetermin
result
relat
replic
yield
indetermin
interpret
initi
process
algorithm
card
queu
qc
champ
program
offic
po
tac
team
qc
review
process
involv
sever
step
includ
review
potenti
reanalysi
initi
card
submiss
upload
reanalyz
ed
xlsx
file
manual
determin
invalid
result
manual
interpret
multitarget
indetermin
result
figur
step
review
process
interpret
algorithm
initi
reinterpret
result
base
reanalyz
card
upload
manual
mark
result
initi
review
po
team
download
file
submit
site
may
choos
accept
result
without
submit
reanalyz
file
upload
ed
xlsx
file
analysi
reanalyz
file
upload
po
team
analyst
option
proceed
manual
review
singl
target
replic
typic
result
invalid
due
intern
control
issu
card
reappear
queue
statu
invalid
review
card
indetermin
multitarget
interpret
remain
autom
manual
singl
target
review
appear
queue
statu
multitarget
review
step
complet
card
set
statu
review
complet
addit
altern
process
scenario
also
implement
tac
interpret
algorithm
includ
resubmiss
targetspecimen
combin
anoth
card
either
due
extract
failur
issu
first
submiss
target
specimen
combin
may
exist
anoth
card
type
either
case
replic
card
targetspecimen
combin
stack
replic
interpret
togeth
gener
new
interpret
invalid
replic
includ
stack
replic
ignor
interpret
algorithm
system
gener
report
specif
case
point
time
complet
set
result
case
span
multipl
card
type
multipl
targetspecimen
combin
potenti
multipl
card
targetspecimen
combin
case
manag
review
tac
result
ensur
complet
prior
gener
case
packet
expert
panel
review
addit
report
queri
provid
po
site
case
manag
track
progress
tac
result
complet
prior
case
packet
gener
laboratori
staff
compet
perform
analysi
tac
assess
use
profici
panel
gener
cdc
describ
two
panel
whole
blood
nasopharyngealoropharyng
swab
transport
media
consist
mock
specimen
extract
test
site
use
appropri
syndrom
tac
train
laboratori
staff
analyz
run
result
sent
run
file
pneumonia
respons
surveil
laboratori
cdc
evalu
compet
assess
initi
laboratorian
prior
begin
test
champ
specimen
offer
thereaft
asneed
basi
base
perform
assess
ongo
review
analyz
tac
file
tac
data
champ
specimen
test
site
review
cdc
laboratorian
upload
unanalyz
analyz
tac
run
file
ed
export
data
file
xlsx
champ
data
portal
site
valid
period
variabl
durat
confirm
satisfactori
perform
test
data
analysi
period
file
review
resolv
indetermin
result
individu
target
specimen
review
unexpect
result
neg
posit
control
resolv
interpret
multitarget
algorithm
result
indetermin
interpret
review
process
enabl
rapid
identif
aberr
result
unexpect
perform
issu
relat
oper
error
reagent
qualiti
aspect
laboratori
workflow
may
requir
investig
correct
action
gener
interpret
threshold
set
amplif
ct
valu
consid
posit
result
long
curv
shape
fluoresc
level
deem
appropri
except
proper
interpret
amplif
curv
fundament
principl
realtim
pcr
emphas
handson
laboratori
train
escherichia
colishigella
assay
ct
cutoff
valu
implement
site
due
potenti
falseposit
result
aris
residu
e
coli
nucleic
acid
enzym
mastermix
extens
valid
assay
support
use
threshold
valu
although
initi
indic
base
assay
valid
perform
plate
format
develop
phase
interpret
threshold
implement
sever
addit
assay
assess
assay
perform
tac
base
review
file
site
earli
valid
period
includ
hepat
e
viru
consid
indetermin
ct
astroviru
chikungunya
viru
dengu
viru
middl
east
respiratori
syndrom
coronaviru
rift
valley
fever
viru
rubella
viru
salmonella
enterica
paratyphi
zika
viru
consid
indetermin
ct
addit
qualiti
assur
plan
implement
pend
full
execut
materi
transfer
agreement
cdc
site
laboratori
institut
ongo
qualiti
assur
test
consist
nucleic
acid
extract
primari
specimen
tac
test
specimen
site
pneumonia
respons
surveil
laboratori
cdc
develop
implement
multiplex
tac
configur
screen
divers
specimen
type
allow
comprehens
evalu
infecti
caus
death
champ
tac
augment
patholog
analysi
postmortem
specimen
clinic
data
inform
specifi
microorgan
contribut
death
case
attribut
death
specif
pathogen
rather
syndrom
pneumonia
sepsi
diarrheal
diseas
provid
action
inform
commun
implement
potenti
lifesav
intervent
largescal
data
analysi
help
priorit
need
new
vaccin
antimicrobi
importantli
technolog
perform
local
train
staff
tac
ideal
platform
multipathogen
detect
lowresourc
set
vast
potenti
expans
beyond
champ
ensur
highest
qualiti
data
champ
tac
laboratori
protocol
care
develop
use
empir
test
whenev
possibl
addit
literatur
review
consult
subject
matter
expert
laboratori
protocol
modifi
site
need
profici
test
implement
ensur
proper
train
compet
test
personnel
well
minim
intersit
variat
result
differ
nucleic
acid
extract
platform
special
effort
made
incorpor
effect
pathogen
inactiv
step
protect
laboratori
staff
due
potenti
presenc
highli
transmiss
pathogen
capabl
caus
sever
infect
inactiv
also
ensur
complianc
nation
intern
law
guidelin
regard
handl
select
agent
ongo
technic
support
remot
onsit
train
personnel
compet
assess
qualiti
assur
test
data
review
continu
throughout
durat
champ
test
site
laboratori
mani
advantag
use
tac
champ
also
substanti
number
complex
challeng
one
limit
tac
pathogen
includ
panel
select
priori
creat
potenti
bia
toward
identif
although
specimen
store
central
repositori
test
later
addit
pathogen
interest
use
newer
test
method
specimen
type
collect
test
divers
complex
matric
requir
special
specimen
process
address
focus
develop
specimen
process
nucleic
acid
extract
protocol
although
effort
limit
materi
avail
use
valid
includ
clinic
specimen
case
assay
unabl
perform
comprehens
valid
use
clinic
specimen
especi
rare
pathogen
even
greater
challeng
exist
beyond
technic
logist
issu
asid
technic
challeng
simpl
abund
data
present
inher
challeng
develop
custom
data
portal
champ
enabl
manag
vast
amount
data
gener
case
case
nucleic
acid
larg
number
potenti
pathogen
detect
particularli
nonsteril
site
specimen
attribut
detect
organ
caus
death
extrem
complex
detect
pathogen
nucleic
acid
necessarili
indic
contribut
diseas
state
death
mani
potenti
pathogen
organ
may
present
longterm
carriag
state
especi
upper
respiratori
gastrointestin
specimen
yet
nearli
imposs
distinguish
statu
use
molecular
detect
method
alon
addit
microorgan
may
dissemin
origin
site
infect
time
lead
follow
death
howev
tac
result
highli
valuabl
adjunct
postmortem
tissu
patholog
studi
help
suggest
need
special
stain
immunohistochemistri
test
see
martin
et
al
supplement
evalu
perform
investig
extent
perimortem
dissemin
pathogen
detect
caus
death
determin
includ
impact
time
death
complet
mit
procedur
evalu
concord
pathogen
detect
use
patholog
molecular
test
also
plan
product
tac
configur
custom
assay
requir
substanti
preproduct
step
qc
test
throughout
process
distribut
tac
ancillari
reagent
well
inventori
manag
also
requir
success
procur
produc
distribut
champsspecif
tac
ancillari
reagent
includ
custom
posit
control
materi
site
laboratori
outsid
champ
lack
commerci
avail
studyspecif
tac
configur
perhap
greatest
barrier
tac
implement
despit
challeng
tac
well
suit
infecti
diseas
surveil
outbreak
respons
research
develop
effort
present
elsewher
expand
util
improv
breadth
pathogen
panel
assay
perform
characterist
keep
capacitybuild
goal
champ
global
prepared
respons
initi
cdc
custom
tac
made
avail
casebycas
basi
outbreak
investig
champ
tac
employ
rapidli
identifi
neisseria
meningitidi
caus
agent
outbreak
liberia
implement
similar
custom
tac
configur
support
largescal
surveil
studi
examin
infecti
etiolog
children
neonat
pair
tac
proven
use
modern
tool
global
diseas
surveil
outbreak
respons
even
resourcelimit
set
howev
infecti
diseas
diagnost
rapidli
evolv
continu
advanc
inevit
dramat
increas
widespread
use
nextgener
sequenc
technolog
clinic
academ
public
health
laboratori
worldwid
signal
substanti
shift
laboratori
capac
cultureindepend
diagnost
test
repres
applic
advanc
technolog
clinic
diagnost
diseas
surveil
champ
move
forward
continu
pursu
emerg
advanc
technolog
applic
mit
specimen
test
continu
improv
reagent
equip
analysi
pipelin
target
resequenc
metagenom
may
enabl
widespread
use
approach
resourcelimit
set
champ
site
interest
pursu
implement
deep
sequenc
analysi
specimen
pathogen
identifi
use
tac
may
provid
good
start
point
implement
method
howev
nextgener
sequenc
method
current
costprohibit
mani
set
technic
barrier
laboratori
infrastructur
equip
technic
support
reagent
procur
may
restrict
factor
access
bioinformat
resourc
high
perform
comput
capac
major
obstacl
implement
examin
specimen
uniqu
biomark
may
also
provid
ad
valu
caus
death
determin
howev
method
requir
substanti
develop
prior
implement
clinic
specimen
within
laboratori
resourcelimit
set
champ
unpreced
approach
address
global
dispar
childhood
death
mani
novel
aspect
includ
implement
advanc
laboratori
method
postmortem
specimen
attribut
specif
pathogen
caus
death
tac
broad
flexibl
multipathogen
detect
platform
ideal
diseas
surveil
outbreak
respons
use
innov
appli
multiplex
pcr
technolog
microfluid
array
vastli
increas
number
pathogen
screen
small
amount
primari
specimen
applic
tac
within
champ
network
herald
potenti
wider
use
global
diseas
surveil
moreov
use
tac
champ
first
applic
technolog
postmortem
specimen
test
combin
comprehens
develop
implement
card
custom
data
manag
system
along
ongo
technic
support
champ
program
offic
technic
partner
make
system
model
futur
global
diseas
surveil
network
